Menu

+ SHARE

Eshoo Holds Hearing to Address Broken Global Pharmaceutical Supply Chain

October 30th, 2019

WASHINGTON, D.C.— Today, Energy and Commerce Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) held a hearing to address the inadequacies of the global pharmaceutical supply chain and the broken generic drug industry.

To watch Chairwoman Eshoo’s opening statement, click HERE.

“There is a hidden health care crisis in our country that will affect us all, and we’re not talking about it: the crippling inadequacy of the American drug supply.” Rep. Eshoo said. “I’m issuing a call to action to the FDA, to the pharmaceutical industry, and to my fellow Members of Congress to take this problem seriously and work with me to address it.”

Today, 90 percent of the medications that Americans take are generics because of affordability. But the generic industry faces serious threats affecting American public health and national security. The hearing addressed three major crises in the global pharmaceutical supply chain:

  • Shortages of lifesaving medications – U.S. hospitals are rationing critical drugs. This month, children and their families discovered that they may not be able to get the pediatric cancer drug Vincristine due to a drug shortage.
  • Subpar manufacturing – Contaminated drugs have contributed to drug shortages. This year, there have been recalls of common blood pressure medications because they contain carcinogens. One of the drugs affected, Losartan, is the ninth most commonly used drug in the U.S.
  • Overreliance on foreign production – The U.S. is highly dependent on foreign production of critical medications. China globally dominates the manufacturing of active pharmaceutical ingredients (API), gaining a chokehold over the global supply of essential drugs, like penicillin. Beijing could use U.S. dependence for critical drugs as an economic weapon and exploit the health and safety of the American public and our Armed Forces.

The hearing’s expert witnesses included Dr. Janet Woodcock from the Food and Drug Administration, Commissioner Michael Wessel of the U.S.-China Economic and Security Review Commission, Mr. David Gaugh from the Association for Accessible Medicines, and investigatory public health author Ms. Rosemary Gibson.

Congresswoman Eshoo is leading the effort to address threats posed by the global pharmaceutical supply chain, collaborating with Intelligence Committee Chairman Adam Schiff to address the public health and national security risks.

###

Get Updates from Anna

How Can Anna Help You?

In this section, you will find information on the many ways my office can help you and your family. Below is a list of the issues we commonly address. If you cannot find what you're looking for, please either email me or call my Palo Alto District Office and we will do our best to answer any questions you may have.

Anna's Voting Record

View All

Thomas Bill Search

@RepAnnaEshoo

Throughout my service in Congress, I've worked to increase research and funding for #PancreaticCancer, one of the d… https://t.co/ddZDS7xu5L

November 21st, 2019

@RepAnnaEshoo

RT @HouseDemocrats: The Fifth Day Public Hearing of the Presidential Impeachment Inquiry https://t.co/XwGQVEQ4eU

@RepAnnaEshoo

RT @USRepMikeDoyle: @EnergyCommerce I worked with my colleague @RepAnnaEshoo to ensure that language from her #TrueFeesAct was included in…

November 20th, 2019

@RepAnnaEshoo

RT @JRosenworcel: We need more #WiFi. That’s why I have long worked with my colleague @mikeofcc to explore using the 5.9 GHz for unlicensed…

@RepAnnaEshoo

RT @HouseDemocrats: The Fourth Day Public Hearing for the Presidential Impeachment Inquiry https://t.co/wNwGFwsHNP

@RepAnnaEshoo

RT @HouseDemocrats: The Third Public Hearing of the Impeachment Inquiry https://t.co/XJ9xGyIM2W

November 19th, 2019

Text SizeA A A